Small study aims to pinpoint ideal oxytocin dose for C-Section moms
NCT ID NCT05290129
First seen Apr 20, 2026 · Last updated Jun 21, 2026 · Updated 14 times
Summary
This study is testing the lowest effective dose of oxytocin to keep the uterus contracted after a C-section in women who have been in labor. Oxytocin is a drug commonly used to prevent postpartum hemorrhage. The trial will enroll 40 women and adjust the dose based on each previous patient's response. The goal is to find a dose that works well with fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
RECRUITINGToronto, Ontario, M5G1X5, Canada
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Oxytocin (Pitocin)
What this could lead to
If successful, this could help doctors use the lowest effective oxytocin dose to prevent postpartum hemorrhage after C-section, reducing side effects.
What could go wrong
This is a very small, early dose-finding study with only 40 participants. Results may not apply to all women, and the optimal dose found may still fail to prevent bleeding in some cases.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.